Active Not RecruitingNCT04685590
Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study
PHASE2 · 48 planned enrolment
- Countries listed
- 2
- Registry update
- April 1, 2026
immortal.lifeVerify the exact trial registrations behind a company, intervention, programme or topic count.
Showing 1–1 of 1. Every record below meets all the filters shown above.
PHASE2 · 48 planned enrolment